ArticleEye and vision (London, England)2026
Choroidal vascular biomarkers for macular neovascularization in chronic central serous chorioretinopathy: insights from widefield indocyanine green angiography.
Article in Eye and vision (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the correlation between choroidal vasculature characteristics and the formation of macular neovascularization (MNV) in patients with chronic central serous chorioretinopathy (CSC), based on widefield indocyanine green angiography (WF-ICGA).
methodsThis was a retrospective, observational study. Patients with chronic CSC with complete medical records and multimodal imaging conducted between September 2022 and June 2025, were included. Eyes with chronic CSC were divided into the MNV and non-MNV groups based on the presence or absence of MNV. WF-ICGA was performed to obtain choroidal characteristics, including vortex vein (VV), dominant VV (DVV), posterior VV, intervortex venous anastomosis (IVA), and age-related scattered hypofluorescent spots on late-phase indocyanine green angiography (ASHS-LIA). Choroidal characteristics were quantitatively and qualitatively assessed and compared between eyes with and without MNVs.
resultsA total of 293 eyes from 212 patients (164 males, 77.36%) were analyzed. Of these, 96 presented with secondary MNV (32.76%), whereas 197 did not. Compared with that of the non-MNV group, the MNV group exhibited a more advanced age and worse visual acuity (all P < 0.001). Regarding choroidal characteristics, MNV cases more frequently exhibited an asymmetric distribution pattern (P = 0.032), solitary DVV (P = 0.041), superotemporal DVV location (P = 0.005), macular IVA (P = 0.027), and ASHS-LIA (P < 0.001). In the generalized linear-mixed model, which was adjusted for age, sex, and symptom duration, the occurrence of MNV correlated with the presence of superotemporal DVV, macular IVA, and ASHS-LIA (P < 0.001, P = 0.003, and P = 0.011, respectively).
conclusionWF-ICGA-derived choroidal vascular characteristics were identified as potential biomarkers for the development of MNV in eyes with chronic CSC. The presence of superotemporal DVV, macular IVA, and ASHS-LIA may serve as independent associated factors for predicting the development of MNV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.